BPC-157 is a synthetic 15-amino acid peptide sequence derived from a protective protein found in human gastric juice
the botanical active ingredient has at least 25 fold, at least 30 fold, at least 35 fold, at least 40 fold, at least 45 fold, at least 50 fold, at least 55 fold, at least 60 fold, at least 65 fold, at least 70 fold, at least 75 fold, at least 80 fold, at least 85 fold, at least 90 fold, at least 95 fold, at least 100 fold, at least 110 fold, at least 120 fold, at least 130 fold, at least 140 fold at least 150 fold, or at least 200 fold Nuclear factor-erythroid-2-related factor 2 (Nrf2) transcription factor-activating potential as compared to an untreated control
Administration Considerations: Treatment approach, dosing, and frequency should be guided by a licensed clinician and dispensing pharmacy
In vivo pharmacokinetics, conducted in Sprague-Dawley rats, showed sustained PX plasma levels over two weeks, with a maximum plasma concentration of 19.06 4.73 ng/mL observed at 48 0.25 h
The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid